Skip to main content

STK-03: Anticoagulation Therapy for Atrial Fibrillation/Flutter

CBE ID
0436e
Endorsement Status
Not Endorsed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Full Year 2015
Is Under Review
No
1.3 Measure Description

This measure captures the proportion of ischemic stroke patients with atrial fibrillation/flutter who are prescribed anticoagulation therapy at hospital discharge.

This measure is a part of a set of eight nationally implemented measures that address stroke care (STK-1: Venous Thromboembolism (VTE) Prophylaxis, STK-2: Discharged on Antithrombotic Therapy, STK-4: Thrombolytic Therapy, STK-5: Antithrombotic Therapy By End of Hospital Day 2, STK-6 Discharged on Statin Medication, STK-8: Stroke Education, and STK-10: Assessed for Rehabilitation) that are used in The Joint Commission’s hospital accreditation and Disease-Specific Care certification programs. STK-3, Anticoagulation Therapy for Atrial Fibrillation/Flutter, is one of six of the measures in this set that have been reengineered as eCQMs and are included in the EHR Incentive Program and Hospital Inpatient Quality Reporting Program.

    • 1.14 Numerator

      Patients prescribed anticoagulation therapy at hospital discharge.

    • 1.15 Denominator

      Patients with a principal diagnosis of ischemic stroke, history of atrial ablation, and current or history of atrial fibrillation/flutter.

    • Exclusions

      Denominator Exclusions:
      • Patients with comfort measures documented.
      • Patients admitted for elective carotid intervention. This exclusion is implicitly modeled by only including non-elective hospitalizations.
      • Patients discharged to another hospital.
      • Patients who left against medical advice.
      • Patients who expired.
      • Patients discharged to home for hospice care.
      • Patients discharged to a health care facility for hospice care.

      Denominator Exceptions:
      • Patients with a documented reason for not prescribing anticoagulation therapy at discharge.

    • 1.13a Data dictionary not attached
      No
    • Most Recent Endorsement Activity
      Not Endorsed Neurology Project 2015-2016
    • Steward
      The Joint Commission
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      Measure specifications are in the Public Domain

      LOINC(R) is a registered trademark of the Regenstrief Institute.

      This material contains SNOMED Clinical Terms (R) (SNOMED CT(c)) copyright 2004-2014 International Health Terminology Standards Development Organization. All rights reserved.

    • Risk Adjustment
      No risk adjustment or risk stratification
      Risk adjustment approach
      Off
      Risk adjustment approach
      Off
      Conceptual model for risk adjustment
      Off
      Conceptual model for risk adjustment
      Off